Lyell Wealth Management LP Decreases Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Lyell Wealth Management LP reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.6% during the 4th quarter, Holdings Channel reports. The fund owned 20,722 shares of the exchange traded fund’s stock after selling 783 shares during the period. Lyell Wealth Management LP’s holdings in SPDR S&P Biotech ETF were worth $1,850,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in XBI. EPG Wealth Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after acquiring an additional 278 shares in the last quarter. Tennessee Valley Asset Management Partners purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $44,000. Wetzel Investment Advisors Inc. purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $45,000. Sheets Smith Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at $55,000. Finally, Life Planning Partners Inc purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $64,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock traded down $1.53 during trading on Thursday, hitting $82.41. The company’s stock had a trading volume of 11,363,923 shares, compared to its average volume of 11,698,528. The stock has a market capitalization of $6.40 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. The stock’s fifty day moving average is $93.10 and its 200 day moving average is $84.57. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.